Synthesis, characterization, and cytotoxic properties of mono- and di-nuclear cobalt(II)-polypyridyl complexes

被引:23
作者
Eskandari, Arvin [1 ]
Kundu, Arunangshu [2 ]
Lu, Chunxin [3 ]
Ghosh, Sushobhan [2 ]
Suntharalingam, Kogularamanan [1 ]
机构
[1] Kings Coll London, Dept Chem, London, England
[2] Gauhati Univ, Dept Chem, Gauhati, India
[3] Qinzhou Univ, Guangxi Coll & Univ Key Lab Beibu Gulf Oil & Nat, Qinzhou 535011, Peoples R China
关键词
COBALT-ALKYNE COMPLEXES; CANCER-THERAPY; BIOLOGICAL EVALUATION; ANTICANCER AGENTS; CRYSTAL-STRUCTURE; ARSENIC TRIOXIDE; ANTITUMOR DRUGS; METAL-COMPLEXES; HISTONE H2AX; DNA-DAMAGE;
D O I
10.1039/c8dt00577j
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
We report the synthesis and characterisation of mono- and di-nuclear cobalt(ii) complexes (1-3) containing L-1, a polypyridyl ligand with pyrazole moieties. DNA binding studies suggest that the mono-nuclear complex, 1, binds to DNA via the grooves prior to inducing oxidative DNA cleavage whereas the larger di-nuclear complexes, 2 and 3, bind to DNA via the grooves and through intercalation prior to inducing oxidative DNA cleavage. The cobalt(ii) complexes display micromolar potency towards U2OS (bone osteosarcoma), HepG2 (liver hepatocellular carcinoma), and GM05757 (normal human fibroblast) cells, comparable to clinically used platinum agents, cisplatin and carboplatin. The cellular mechanism of action studies show that the most effective cobalt(ii) complex, 2, enters U2OS cells, penetrates the nucleus, induces genomic DNA damage, and triggers caspase-dependent apoptosis in a p53-independent manner. This study highlights the potential of di-nuclear cobalt(ii) complexes as artificial oxidative metallonucleases and tangible cancer cell-potent agents.
引用
收藏
页码:5755 / 5763
页数:9
相关论文
共 55 条
[1]   Synthesis and structure elucidation of a cobalt(II) complex as topoisomerase I inhibitor: In vitro DNA binding, nuclease and RBC hemolysis [J].
Ahmad, Musheer ;
Afzal, Mohd ;
Tabassum, Sartaj ;
Kalniska, Bozena ;
Mrozinski, Jerzy ;
Bharadwaj, Parimal K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 74 :683-693
[2]   Metal-mediated DNA damage and cell death: mechanisms, detection methods, and cellular consequences [J].
Angele-Martinez, Carlos ;
Goodman, Craig ;
Brumaghim, Julia .
METALLOMICS, 2014, 6 (08) :1358-1381
[3]   Introduction: The history of arsenic trioxide in cancer therapy [J].
Antman, KH .
ONCOLOGIST, 2001, 6 :1-2
[4]   Modifications of DNA by platinum complexes - Relation to resistance of tumors to platinum antitumor drugs [J].
Brabec, V ;
Kasparkova, J .
DRUG RESISTANCE UPDATES, 2005, 8 (03) :131-146
[5]   ATM phosphorylates histone H2AX in response to DNA double-strand breaks [J].
Burma, S ;
Chen, BP ;
Murphy, M ;
Kurimasa, A ;
Chen, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42462-42467
[6]   Synthesis, structure and metallation of spiro-N3P3(O2C12H8)(OC5H4N-2)4:: A heptacoordinate Co(II) in the molecular structure of N3P3(O2C12H8)(OC5H4N-2)4•Co(NO3)2 [J].
Chandrasekhar, Vadapalli ;
Pandian, Balasubramanian Murugesa ;
Azhakar, Ramachandran .
POLYHEDRON, 2008, 27 (01) :255-262
[7]  
Cressey PB, 2017, INORGANICS, V5, DOI 10.3390/inorganics5010012
[8]   The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells [J].
Cressey, Paul B. ;
Eskandari, Arvin ;
Bruno, Peter M. ;
Lu, Chunxin ;
Hemann, Michael T. ;
Suntharalingam, Kogularamanan .
CHEMBIOCHEM, 2016, 17 (18) :1713-1718
[9]   Cisplatin in cancer therapy: Molecular mechanisms of action [J].
Dasari, Shaloam ;
Tchounwou, Paul Bernard .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 :364-378
[10]   Biological evaluation of cobalt(II) complexes with non-steroidal anti-inflammatory drug naproxen [J].
Dimiza, Filitsa ;
Papadopoulos, Athanasios N. ;
Tangoulis, Vassilis ;
Psycharis, Vassilis ;
Raptopoulou, Catherine P. ;
Kessissoglou, Dimitris P. ;
Psomas, George .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 107 (01) :54-64